Skip to main content

Allergy

  • CHPA adds 8 new members, names Perrigo EVP chairman of the board

    WASHINGTON — The Consumer Healthcare Products Association on Thursday elected Jeff Needham as chairman of the CHPA Board of Directors at its June meeting. Needham serves as EVP and general manager of U.S. Consumer Healthcare for Perrigo Company, the nation’s largest manufacturer of over-the-counter private label products for the store brand market.


    Needham succeeds Patrick Lockwood-Taylor, who was previously VP of Personal Health Care North America and Global Digestive Wellness at Proctor & Gamble.

  • Smith Drug Co. gets front-end productivity boost through HRG 360 program

    WAUKESHA, Wis. – Smith Drug Company recently utilized Hamacher Resource Group's 360° Store Assessment program in an effort to boost front-end productivity across its independent retail pharmacy operators, HRG announced Tuesday.

  • HDA recognizes pharmaceutical and consumer product manufacturers with DIANA honors

    COLORADO SPRINGS, Colo. — The newly rebranded Healthcare Distribution Alliance on Tuesday recognized outstanding pharmaceutical and consumer product manufacturers with the annual Distribution Management Awards for Notable Achievements in Healthcare (DIANA).
     

  • HDMA rebranded as Healthcare Distribution Alliance

  • CHPA testifies on impact FDA's proposed OTC Monograph User Fees may have on innovation

    WASHINGTON — Testifying before the Food and Drug Administration, the Consumer Healthcare Products Association on Friday expressed cautious optimism on the impact OTC Monograph User Fees may have on OTC innovation. 
     

  • HRG to moderate front-end focused session at HDMA BLC

    WAUKESHA, Wis. – Hamacher Resource Group will serve as moderator of the session, “Ask the Distributors – How to Fuel the Front-end,” on June 13 at the Front-end Forum, part of the Healthcare Distribution Management Association Business and Leadership Conference at the Broadmoor Resort in Colorado Springs, Colo., the company announced Tuesday. 
     

  • Perrigo announces FDA approval of store brand equivalent to Flonase

    DUBLIN -  The national brand equivalent of GlaxoSmithKline's Flonase will soon be shipping to store shelves with the announcement Monday that Perrigo and its partner West-Ward Pharmaceuticals on Tuesday gained approval from the U.S. Food and Drug Administration.

    "This product approval and launch demonstrates the power of Perrigo's OTC platform," stated John Hendrickson, Perrigo CEO. "Our team has made significant efforts to bring this important product to our customers and consumers in the U.S."

  • DSN, Mack Elevation host first-ever Future Leaders Summit

    CHICAGO — There are more than 58,000 books dedicated to the subject of leadership for sale on Amazon. Yet, it's still one of the most misunderstood topics in business, Mack Elevation Forum founder and managing director Dan Mack told an audience of almost 150 executives gathered here, Tuesday, at the Chicago Art Institute , setting the stage for the first-ever Future Leaders Summit.
     
X
This ad will auto-close in 10 seconds